Epidermal growth factor receptor inhibitors in colorectal cancer treatment: what's new? - Wikidata - awgldk - TriplyDB

Epidermal growth factor receptor inhibitors in colorectal cancer treatment: what's new?

Epidermal growth factor receptor inhibitors in colorectal cancer treatment: what's new?

http://www.wikidata.org/entity/Q34382797

about

Inhibition of Rho-associated coiled-coil containing protein kinase enhances the activation of epidermal growth factor receptor in pancreatic cancer cells.Systemic treatment of advanced colorectal cancer: tailoring therapy to the tumor.Predicting response to vascular endothelial growth factor inhibitor and chemotherapy in metastatic colorectal cancer.Innovations in chemotherapy and radiation therapy: Implications and opportunities for the Asia-Pacific Rim.Epidermal growth factor receptor mutations in colorectal cancer patients TNF-α converting enzyme-mediated ErbB4 transactivation by TNF promotes colonic epithelial cell survival Cellular and molecular effects of yeast probiotics on cancer.Clinical use of anti-epidermal growth factor receptor monoclonal antibodies in metastatic colorectal cancer.Tumor-specific apoptosis caused by deletion of the ERBB3 pseudo-kinase in mouse intestinal epithelium.Current concepts in research related to oncogenes implicated in salivary gland tumourigenesis: a review of the literature.Carcinogenesis in IBD: potential targets for the prevention of colorectal cancer.Epidermal growth factor receptor: an important target in esophageal cancer.Cetuximab ± chemotherapy enhances dendritic cell-mediated phagocytosis of colon cancer cells and ignites a highly efficient colon cancer antigen-specific cytotoxic T-cell response in vitro.Saccharomyces boulardii inhibits EGF receptor signaling and intestinal tumor growth in Apc(min) mice.Pathological significance of epidermal growth factor receptor expression and amplification in human gliomas.Expression of p53 & epidermal growth factor receptor in glioblastoma.PI3KCA/PTEN deregulation contributes to impaired responses to cetuximab in metastatic colorectal cancer patients

P2860

Q33948775-524F2B0B-3329-4E5A-AD01-E48C3101BBCB Q34408875-5DE6953E-DB82-4B39-B096-B9060B514E29 Q34897393-C4672F72-F3D2-4B2E-80CE-89B4CA54E325 Q34991655-020D4B07-6F89-4DDA-A553-389FEE0874B3 Q35134625-3AC021BD-1CF8-4997-BAAE-ADC995265ECE Q35159615-4EF38289-B033-43F9-803A-58CC40C6ABC2 Q36113199-144CD4BA-0EA3-4ABC-8128-B828C9F1F2D5 Q37316037-FBEE49BF-68DA-4AE3-9DD8-43434F1DDFF0 Q37328476-7A68C91F-C760-49FD-8668-312CD4023A3D Q37422555-6B2F16DC-8E5E-4C06-82E0-578D5479720D Q37464715-9AC91FEE-D99D-4ED7-9196-002AE789DFB0 Q38121640-45EA1DE9-BDFE-4A78-93CA-7FB18EC85A5F Q39535140-E4AB2F6B-EBEC-45FA-842A-E75AF51F7A7F Q41876318-EA66E429-2C00-48ED-A3A2-991CBB7C0BE6 Q48376998-F0FBD482-F782-42F4-93F6-D7508DDEE1DA Q55317834-8AF06F1D-3389-48C6-8AFF-D3F6FF4DB2C9 Q58813317-5BDABF67-60EB-4170-91C4-F2028AEC258D

P2860

Epidermal growth factor receptor inhibitors in colorectal cancer treatment: what's new?

http://www.wikidata.org/entity/Q34382797

description

2007 nî lūn-bûn

@nan

2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Epidermal growth factor receptor inhibitors in colorectal cancer treatment: what's new?

@ast

Epidermal growth factor receptor inhibitors in colorectal cancer treatment: what's new?

@en

Epidermal growth factor receptor inhibitors in colorectal cancer treatment: what's new?

@nl

type

label

Epidermal growth factor receptor inhibitors in colorectal cancer treatment: what's new?

@ast

Epidermal growth factor receptor inhibitors in colorectal cancer treatment: what's new?

@en

Epidermal growth factor receptor inhibitors in colorectal cancer treatment: what's new?

@nl

prefLabel

Epidermal growth factor receptor inhibitors in colorectal cancer treatment: what's new?

@ast

Epidermal growth factor receptor inhibitors in colorectal cancer treatment: what's new?

@en

Epidermal growth factor receptor inhibitors in colorectal cancer treatment: what's new?

@nl

P1433

Q34382797-E29256C8-9CDC-4520-B7FC-50BA16FE8A98

P1476

Q34382797-B8AFD3FB-99B6-4285-8E34-CD5EC34A37EF

P2093

Q34382797-328D52E4-4E0D-41E7-85BE-E77B30505D07

Q34382797-594478EC-1A31-432E-A161-E7B66E7229B1

Q34382797-61B4CF98-5B40-45E8-B693-C325B17FA103

Q34382797-85CCC082-7879-41FA-AC2D-2A1DE030A900

Q34382797-9E09EE0E-32FD-43EB-B269-B544A70639A7

Q34382797-C06FE49E-1543-47D4-B234-A28E71A8E948

Q34382797-FB666550-8727-4EA1-9DE4-E5E6EA65B109

P2860

Q34382797-06372E7D-52B6-4CDC-AED0-8D3744551017

Q34382797-0A6ED5EE-1A0A-48C5-AC6E-0771A9F5C351

Q34382797-15CB249A-966A-4FCB-82FA-4A335C512DAB

Q34382797-187B07F0-A4C2-426C-8B25-D451C6386B54

Q34382797-20CEC20E-F95B-4D7F-9197-F0A91E00C0D1

Q34382797-2C243B3F-A990-4E32-8604-ACED463D416B

Q34382797-3022C516-2CCA-451B-8165-DA8F4B3D852B

Q34382797-3163CC76-D21D-49D1-9121-86354E4FEE46

Q34382797-34E4B75A-B823-48DC-B5BA-C034AAFC4E1A

Q34382797-386267D4-5D16-41C3-9573-D9F02D06C1A4

P304

Q34382797-2C5D97FF-A1DA-4986-BF4A-0284549DADE5

P31

Q34382797-FA222ECC-9744-47B0-B374-AF0678DA6275

P356

Q34382797-B3976CE0-74A0-4507-9351-D47E15438979

P407

Q34382797-D08F1A2B-3842-4602-842F-5C21AD09B860

P433

Q34382797-31EE7364-AC6A-462E-811B-185D993F5DCB

P478

Q34382797-40B6B8A2-821E-45F6-B94F-844E9A8B2FE2

P577

Q34382797-19D2DF1F-0C3A-4FD5-862D-7CF5287770B6

P5875

Q34382797-7EBFD011-3C9E-4FC4-ABFE-1E7942DE38B5

P698

Q34382797-53CA63FA-C572-4C8C-8582-DE3B05316917

P921

Q34382797-8633294E-1AA6-46D0-A4BC-F06CC4BAF623

P932

Q34382797-13FD6EA6-AC51-4851-BD80-8FB3470B8EE5

P356

WJG.V13.I44.5877

P1433

World Journal of Gastroenterology

P1476

Epidermal growth factor receptor inhibitors in colorectal cancer treatment: what's new?

@en

P2093

A Calvo

http://www.w3.org/2001/XMLSchema#string

A Chopitea

http://www.w3.org/2001/XMLSchema#string

A Viudez

http://www.w3.org/2001/XMLSchema#string

I Gil-Bazo

http://www.w3.org/2001/XMLSchema#string

J García-Foncillas

http://www.w3.org/2001/XMLSchema#string

J Rodríguez

http://www.w3.org/2001/XMLSchema#string

M Ponz-Sarvisé

http://www.w3.org/2001/XMLSchema#string

P2860

Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor.

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer.

Untangling the ErbB signalling network

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

Phase I study of the humanized antiepidermal growth factor receptor monoclonal antibody EMD72000 in patients with advanced solid tumors that express the epidermal growth factor receptor

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

EGF-ERBB signalling: towards the systems level

ERBB receptors and cancer: the complexity of targeted inhibitors

Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck.

P304

5877-5887

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V13.I44.5877

http://www.w3.org/2001/XMLSchema#string

P407

P433

44

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2007-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5857036

http://www.w3.org/2001/XMLSchema#string

P698

17990353

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

4205434

http://www.w3.org/2001/XMLSchema#string